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NMR Metabolomics for Stem Cell 
type discrimination
Franca Castiglione1, Monica Ferro1, Evangelos Mavroudakis1,8, Rosalia Pellitteri2, Patrizia 
Bossolasco3, Damiano Zaccheo4, Massimo Morbidelli5, Vincenzo Silani3,6, Andrea Mele1,7, 
Davide Moscatelli  1 & Lidia Cova  3
Cell metabolism is a key determinant factor for the pluripotency and fate commitment of Stem Cells 
(SCs) during development, ageing, pathological onset and progression. We derived and cultured 
selected subpopulations of rodent fetal, postnatal, adult Neural SCs (NSCs) and postnatal glial 
progenitors, Olfactory Ensheathing Cells (OECs), respectively from the subventricular zone (SVZ) and 
the olfactory bulb (OB). Cell lysates were analyzed by proton Nuclear Magnetic Resonance (1H-NMR) 
spectroscopy leading to metabolites identification and quantitation. Subsequent multivariate analysis 
of NMR data by Principal Component Analysis (PCA), and Partial Least Square Discriminant Analysis 
(PLS-DA) allowed data reduction and cluster analysis. This strategy ensures the definition of specific 
features in the metabolic content of phenotypically similar SCs sharing a common developmental 
origin. The metabolic fingerprints for selective metabolites or for the whole spectra demonstrated 
enhanced peculiarities among cell types. The key result of our work is a neat divergence between 
OECs and the remaining NSC cells. We also show that statistically significant differences for selective 
metabolites characterizes NSCs of different ages. Finally, the retrived metabolome in cell cultures 
correlates to the physiological SC features, thus allowing an integrated bioengineering approach for 
biologic fingerprints able to dissect the (neural) SC molecular specificities.
Stem cells (SCs) are undifferentiated cells in organisms, which could indefinitely proliferate or generate differ-
entiated cell types able to perform specific physiological functions. Their organized proliferation and cell fate 
determination allow the formation of both tissues and organs during embryonic development, whereas their 
permanence in restricted niches consents tissue repair and maintenance in adulthood1. Therefore, SCs are cur-
rently used in several biomedical applications, especially to replace or repair pathological tissues in regenerative 
medicine, as well demonstrated for amyotrophic lateral sclerosis2. Stem cell cultures appear as a heterogeneous 
mixture of functional subpopulations, characterized by distinct self-renewal and differentiation biases, able to 
generate a progressively restricted repertoire of cell types (progenitor cells)3. Heterogeneity is also high in other 
SC types, such as pluripotent SCs, Embryonic Stem Cells (ESCs) and induced pluripotent stem (iPS) cells, so their 
application to cell therapy requires accurate selection of pure SCs populations3. To fulfill safety criteria for regen-
erative medicine4, the absence of residual undifferentiated SCs and preparations of pure standardized SCs should 
be guaranteed, as requested by the International Society for Stem Cell Research (ISSCR)5,6.
In this general context, the determination of (univocal) biomarkers able to define SC/cell line identities and 
functions along passages plays an emerging key role for validating scientific studies7, as well as clinical trials or 
cell therapy products1.
Recently, a pivotal role of metabolic pathways has been demonstrated in dictating SC fate since each cell 
metabolomic profile appears directly influenced by its proliferative or differentiative state8, as well as by the 
surrounding environment. Therefore, Nuclear Magnetic Resonance (NMR)-based metabolomic analysis9,10 is 
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constantly gaining importance in the study of SC biology and for the discovery of biomarkers in vitro or directly 
in the Central Nervous System (CNS)11–15. Interestingly, alterations of metabolic demands has been also linked 
to ageing, (neuro)degenerative diseases16 and cancer17 with potential clinical application to improve diagnostic 
accuracy, define prognosis as well as predict and monitor treatment efficacy18,19. Robustness and reliability of 
quantitative analysis by proton NMR (1H-NMR) in metabolomics is supported by several reports wherein SC 
normal/tumor subtypes or their conditioned media may be efficiently distinguished by specific NMR patterns, as 
well as metabolites12,20,21. In this general scenario it should be pointed out that the possible use of standard NMR 
spectrometers and a sample preparation without any special requirement (e.g. the use of 13C-hyperpolarized ini-
tiators) is considered a plus for metabolomic profiling22,23.
Actively proliferating Neural Stem Cells (NSCs) were here compared to a selected glial subpopulation, the 
progenitor Olfactory Ensheathing Cells (OECs), to test the reliability of 1H-NMR technique in providing effective 
biomarkers for cell discrimination. NSCs are undifferentiated multipotent SCs located in the SubVentricular 
Zone (SVZ) of adult mammalians and able to generate differentiated both neuronal and glial progeny through 
intermediate progenitors24. Multipotent NSCs are present all along brain development: in embryonic brains they 
are mainly involved in tissue formation and neuron production, whereas later (P1) they participate to the func-
tional development and remodeling of brain’s connections. Finally, in adult life NSCs remain quiescent only in 
specific brain areas and can be re-activated “on demand” to generate new neurons functionally integrated into the 
adult mammalian brain24. Therefore, NSCs shift their main commitment in vivo from creation of a brain neural 
network (E12) and its refinement (P1) to physiological (single) cell substitution in damaged or aged brain tissue. 
NSCs can be isolated from embryonic/postnatal or adult brains and maintained in vitro, but they are undistin-
guishable by cellular phenotype, differentiative potential as well as antigenic markers25,26.
More committed glial-like OECs share with NSCs the embryonic SVZ origin, but mainly support healthy 
neuronal homeostasis in the olfactory system. Physiologically, OECs are specific glial progenitor cells envelop-
ing the olfactory nerve which derive from the migratory stream connecting the SVZ to the olfactory bulb (OB) 
(see Supplementary Fig. SI1). They are able to remyelinate demyelinated axons as well as to support regrowth of 
transected axons after transplantation into the adult CNS27. Although NSCs and OECs are functionally different, 
they both express nestin and share a common embryonic derivation (see Supplementary Fig. SI1). We derived 
neuronal progenitor cultures from mice brains of: i) fetal (E12), ii) postnatal (P1) and iii) adult (AD) NSCs from 
the SVZ and iv) postnatal OECs from the OB of P1 mice (see Supplementary Fig. SI1).
In the present work the identification of specific metabolic markers in cultured brain SC types and the com-
parative application of NMR analysis coupled to multivariate analysis for a rapid and easy assessment of stem cell 
peculiar metabolome are reported.
The definition of biological hallmarks/biomarkers and the characterization of phenotypically similar SC types 
by NMR analysis are thus the final goals of the present study.
The metabolic profile of the different SC types was acquired and analyzed via 1H NMR spectroscopy through 
the following steps: i) identification and quantitation of the SC metabolites obtained from the cell cultures by 
1H-NMR spectroscopy, ii) discovery of selective and statistically significant metabolic markers characterizing 
SCs, with focus on the specific profile of OECs in respect to NSCs, and iii) the clustering and differentiation of 
the SC types on the basis of their metabolic profile via multivariate analyses28,29– Principal Component Analysis 
(PCA) and Partial Least Square Discriminant Analysis (PLS-DA) – of the entire 1H-NMR spectra.
Results
Identification of metabolites via 1H NMR Spectroscopy. Analysis of 1H NMR metabolite was per-
formed on the four different, but related, SC types (see Supplementary Fig. SI1) on several independent replicates 
derived from different primary cultures grown in the specific media for several passages, as detailed in experi-
mental section.
The metabolites were extracted for each replicate, as described, afterwards the corresponding 1H-NMR spec-
trum was acquired and analyzed. An example of a full 1H NMR spectrum for the metabolic profile of the SCs 
along with the assignment of the main identified metabolites is shown in Fig. 1. The overlay of the 1H NMR spec-
tra of all the SCs examined is reported in Supplementary Fig. SI2. It is worth mentioning the fact that the specific 
OEC metabolic fingerprint via NMR spectroscopy on cultured cells is presented here for the first time. The 1H 
NMR profiles of all the SCs examined shared the same set of metabolites, although with different peak intensi-
ties. Detailed spectral assignment were supported by the analysis of the two-dimensional 1H Total Correlation 
Spectroscopy (TOCSY) NMR experiments (Supplementary Fig. SI3). The SC metabolome includes different 
biochemical categories, as shown in Figs 1 and 2: non-aromatic amino acids, such as Alanine (Ala), Leucine 
(Leu), Isoleucine (Ile) and Glutamate (Glu, essential for biosynthesis and anaplerosis), di-carboxylic acids, such 
as Succinate (Suc, which plays a crucial role in adenosine triphosphate (ATP) generation in mitochondria) and 
energy metabolism components, mainly Glucose (Glc). Only the anomeric signal of α-D-Glucopyranose (here 
indicated as Glc) was observed at 5.24 ppm, whereas the corresponding signal for the β-anomer was hidden by 
the water peak. Additionally, the presence of the metabolites characteristic of healthy brain (such as total Creatine 
(Cr) and Choline-containing compounds (Cho), both related to enhanced cell membrane turnover in rapidly 
dividing cells) in conjunction with Lactate (Lac) from glycolysis were also observed. Additional categories were 
retrieved, including antioxidants, such as Taurine (Tau), and other metabolites related to energy homeostasis, 
such as Acetate (Ace) as well as Alanine (Ala)1,14,30,31. Finally, the part of the 1H NMR spectrum at high ppm values 
(low field) showed small but significant peaks consistent with aromatic protons. Some signals could be unambig-
uously assigned to aromatic amino acids, such as Tyrosine (Tyr) and Phenylalanine (Phe) (see Fig. 1). Such peaks 
were detected, with variable intensity, in the majority of SC samples. The other aromatic peaks visible in Fig. 1 
could not be assigned and will not be further discussed.
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NMR profiling of each SC type. Quantitative evaluation of metabolites concentrations was performed by 
integration and subsequent normalization of specific peaks (see Fig. 1). The histogram of the main metabolite 
concentrations is shown in Supplementary Fig. SI4 and the corresponding Pareto analysis for each cell type is 
presented in Fig. 2A. In Fig. 2B more representative measured nine metabolites (around 75% of the analysed 
metabolites) are depicted with indication of the correlated main metabolic pathways. Some metabolites were 
specifically abundant in all NSCs (Tau and Glc) or only in OECs (Ala) whereas Lac and Ace were considerably 
present in all cell types. The complete list of all metabolic Kegg pathways related to the metabolites is reported in 
Supplementary Fig. SI5.
The goal of a quantitative, significant test based on the metabolic profile was achieved by comparing the sin-
gle metabolite variation among cell types. The difference in the metabolite concentration was tested by one-way 
ANOVA test in search of selective markers for the discrimination of cell types.
The statistical analysis of the NMR data, shown in Fig. 3, identified Tau, Glu, Lac, and Suc as the set of biologi-
cal markers for a differentiative analysis of the four SCs. Indeed, these metabolites significantly varies among cells, 
thus suggesting that the cell metabolome reflects some peculiarities of cell subtypes, irrispectively of a phenotypic 
and antigenic homogeny. We retrived that significant higher Tau and Glu content characterizes AD in comparison 
to all other SC subtypes, whereas no significative differences in metabolite contents were always observed when 
E12 and P1 were compared. Moreover, Lac content significantly varied between E12 or P1 and OECs, whereas 
intracellular Suc amount efficiently discriminated between AD and OECs wherein the statistically lowest levels 
were retrieved (Fig. 3). Interestingly, the metabolic contents for these selected markers efficently differentiated 
OECs from all NSCs and AD from the younger counterparts among NSCs.
The NMR data also pointed out that quantification of the remaining metabolites (such as Cho, Ala, Ace, Cr, 
and Glc (characterized by a large variability)) did not show statistically significant differences within the exam-
ined set of SCs (see Supplementary Fig. SI6). Therefore, we consider these data qualitative and they will not be 
discussed in the next section. Finally, the Glc content and consumption in the different cell types is reported in 
Supplementary Fig. SI7 and discussed in Supplementary Information SI section.
Spatio-temporal cell identification by multivariate NMR analysis. A different and complementary 
approach to the analysis of NMR data is based on multivariate analyses of the NMR spectra: PCA and PLS-DA. 
PCA is an unsupervised method able to uncover meaningful patterns in the data set. It provides a representation 
of the data in a lower-dimensional space, whose coordinates are the principal components (PC).
PLS-DA is a supervised method introducing a bias regarding the total number of cell types (four in this 
work) so the PLS-DA model provides better cluster separation. As PCA separation is achieved only when the 
intra-group variability is remarkably less than the inter-group variability, it provides an unbiased biological 
indication. Therefore, we used PCA analysis in order to obtain initial, unbiased information on the relation-
ships among the datasets of the SC groups. The results are graphically shown in Supplementary Fig. SI8 in a 3D 
score plot and, for a better visualization, a two dimensional projection in the PC1-PC2 plane is also reported in 
Supplementary Fig. SI9A. Both score plots indicate a clear cluster separation between the OECs vs all the other SC 
types. Furthermore, to better sharpen the separation between groups, we carried out the PLS-DA analysis, which 
is presented in Fig. 4 in the form of the 3D score plot. The scores of cell samples are here mapped in the space by 
the first three components PC1, PC2 and PC3, which account for 46.3% of the overall variance. The ellipsoids in 
Fig. 4 show the 95% confidence level and provide a guide for visual observation of cluster separation due to the 
different metabolic content inside cell subtypes. Similarly to the PCA analysis above, the PC1-PC2 projection of 
PLS-DA analysis is reported (in Supplementary Fig. SI9B) to provide an alternative view of the cluster separation 
between OECs and the other SCs. PCA and PLS-DA carried out on the spectral data belonging to the NSC subset 
only, i.e. by excluding OEC’s datasets, did not allow any cluster separation (see Supplementary Fig. SI10), thus 
confirming that the results of Fig. 4 and Supplementary Fig. SI8 are driven by the different metabolic profiles of 
OECs in comparison to the NSC cell types.
Figure 1. Representative 1H NMR spectrum of AD NSC lysate. Peak assignment of specific metabolites is 
indicated as: (1) Leucine (Leu), (2) Isoleucine (Ile), (3) Lactate (Lac), (4) Alanine (Ala), (5) Acetate (Ace), (6) 
Glutamate (Glu), (7) Succinate (Suc), (8) Creatine, (9) Taurine (Tau), (10) Choline (Cho), (11) Glucose (Glc), 
(12) Tyrosine (Tyr), (13) Phenylalanine (Phe).
www.nature.com/scientificreports/
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Figure 2. More representative metabolites for each cell type and the related biological pathways. (A) Pareto 
analysis of main retrieved metabolites’ concentration for each cell type. The histograms report the bars 
in decreasing order for each cell type. The curve on the plot accounts for the cumulative percentage. The 
corresponding values are reported on the secondary y-axis. (B) The analysis of more nine representative 
metabolites in each cell type reveals that both common (Lac, Ace) and differential metabolites (Tau and Glc for 
NSCs; Ala for OECs) comprise for more than 74% of total metabolome. A search in the Kegg pathway database 
reveals main biological topics involving the different metabolites: all NSCs showed higher Tau and Glc levels 
whereas larger Lac amounts characterized OECs. More details on all the involved biological pathways analyzed 
are reported in Supplementary Fig. S5. Abbreviations: ABC transporters = ATP-binding cassette transporters; 
Aromatic a.a. = aromatic amino acids (Tyrosine, Triptophan, Phenylalanine); PPAR = Peroxisome proliferator-
activated receptors; HIF-1 = Hypoxia-inducible factor 1; FoxO = Forkhead box O transcription factors; 
SC = Stem Cells; Sulfur containing a.a. = Sulfur containing amino acids.
www.nature.com/scientificreports/
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Figure 3. Comparison among metabolite concentrations. Each set of graphic reports on the different level of 
the titled metabolite in the four cell subtypes tested by one-way ANOVA statistical analysis. The connectors on 
top of the bars indicate the statistically significant differences and are reported only in the cases of significant 
difference. Statistical significance is indicated in each graph as ***ppp ≤ 0.001, **pp ≤ 0.01 and *p ≤ 0.05 
versus the corresponding sample(s). Error bars are referred to the standard error.
Figure 4. 3D Score plot of PLS-DA analysis. The 3D score plot enlightened the similarities and differences 
among the metabolic fingerprints of each SC type – PLS-DA score plot of PC1 vs PC2 vs PC3 for: E12, P1, AD, 
and OEC SCs. The data points correspond to the examined samples. The proximity of two points reflects the 
metabolic similarity among the corresponding samples. The grouping of each cell type is also outlined by the 
colour code of the points confined in the ellipsoids. Clustering and separation of the points related to OEC is 
clearly indicated by the blue ellipsoid. For the presented analysis, the entire 1H NMR spectrum was divided in 
0.04 ppm regions (bins) for each sample.
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Our decision to reduce the number of animals used for our experiments (following the ethical concerns 
explained at: http://3rs.ccac.ca/en/about/three-rs.html) severely hampered the use of a training set, leading us to 
the choice of internal cross-validation methods32. Therefore, the analysis was cross-validated by the leave-one-out 
validation protocol. The obtained predictive ability Q2 and model fitness R2 were 0.44 and 0.66, respectively, thus 
showing a first evidence of non-overfitting of data. As suggested33, this conclusion needs further confirmation by 
the permutation test. The results in our case for a permutation number = 100 are reported in the Supplementary 
Fig. SI11 (A), along with the corresponding p-value. For clarity, the same test in the case of PLS-DA on NSC sub-
set only is also reported and displayed in Fig. S11(B).
The one dimensional analysis of the loadings for PC1 and PC2 is shown in Fig. 5. The plots illustrate the major 
contribution to PC1 and PC2 (loadings, y-axes) as a function of the NMR chemical shift (x-axes), thus allowing 
to identify the NMR signals carrying the major contribution to the spectral differentiation. The results of Fig. 5 
indicate that the major contributions to the discrimination of OEC and NSC (AD, P1 and E12) are located in four 
different regions: from 0.75 to 1.15 ppm, from 2.19 to 3.52 ppm, from 5.04 to 5.36 ppm and from 6.65 to 8.78 ppm. 
In these spectral regions fall the majority of the signals assigned to Glu, Suc and Tau, which we have highlighted as 
biological markers on the basis of the statistical analysis reported in the previous section. This plot also point out 
that even other amino acids, such as Leu and Ile (which have signals that fall respectively at 0.96 and 0.94 ppm), 
Glc (its H1 signal falls at 5,22 ppm) and some aromatic amino acids (such as Phe) contribute to the separation 
of clusters.The same data sets can be processed in the form of a two-dimensional PLS-DA loading plot, shown 
in Fig. 6, where each point represents an individual bin of the experimental spectrum (the “spectrum binning” 
operation and the meaning of “bin” is detailed in Experimental section at the PCA paragraph). The points of the 
2D loading plot of Fig. 6 can be divided into two sets: those inside the crowded region located in the interval 0–0.1 
of both PC1 and PC2 dimensions (and highlighted for clarity with an ellipse) and those well scattered outside 
the crowded region in the PC1-PC2 plane. These latter points are mostly responsible for the cluster separation 
observed in the score plot of Fig. 4.
The numerical values reported in Fig. 6 are the chemical shift of the corresponding bin. Thus, the loading 
plots, either in the one- or two dimensional mode (Figs 5 and 6, respectively), can be used in to work out which 
regions of the NMR spectrum cause the main differences visible in the score plot.
The analysis of the 2D loading plot added information on the bins affording significant contribution to the 
discrimination among clusters observed in the score plot: it confirms the regions highlighted by the 1D loadings 
plots showed in Fig. 5.
Discussion
Our data demonstrate that the metabolic phenotyping of related SCs with similar intracellular content can be 
achieved by the straightforward application of routine NMR techniques and appropriate statistical analysis. 
As a matter of fact, selected stem/progenitor populations derived from CNS and maintained in culture mainly 
share the same metabolites, although in different proportions possibly reflecting preferential biological pathways 
related to developmental age, stem features and/or biological properties. Therefore, only particular approaches, 
such as multivariate analysis of NMR data (PCA and PLS-DA), can differentiate these cell types capturing their 
metabolic peculiarities. Similarly to others (i.e. Pincus & Theriot34) we found that the multivariate analysis of 
the obtained data may contribute to a quantitative description of biologically significant differences in complex 
systems35, such as SCs.
The best distinction was achieved between NSCs and OECs, due to their qualitative and quantitative metabolic 
differences, both for single metabolite concentrations and elaboration of the complete NMR spectra. Moreover, 
targeted metabolomics of four metabolites (Tau, Lac, Glu, Suc) clearly identifies some statistical differences 
between P1 OECs vs E12/P1/AD NSCs. Concentrations of Tau and Glu also significantly diverged between AD 
NSCs vs P1 OECs as well as between AD vs E12 and P1 NSCs, thus suggesting that some peculiar metabolic 
features characterize AD NSCs. However, no identified metabolic biomarker allowed a clear distinction between 
E12 and P1 NSCs. Concordantly, embryonic and postnatal NSCs in the SVZ mainly derive from the same slowly 
Figure 5. PLS-DA loadings plot of the first two principal component PC1 and PC2 in the one-dimensional 
representation. The x axis shows the spectral binning with the associated chemical shift values. The y axis values 
correspond to the relative weight (loading) of the bins.
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dividing population of neural precursor cells in the embryonic ganglionic eminence36, whereas AD NSCs are 
specifically determined in early embryonic development37.
Differently from published literature, our NMR analysis was conducted on selected/pure brain cell subpopula-
tions maintained in cultures: NSCs isolated at different ages and cultured as neurospheres (non-adherent, spher-
ical cultures of clonally derived precursors)24; and OECs, a distinct glial cell population with specific biological 
and molecular properties38. Therefore, the NMR profiles we present here are deeply different from the published 
NMR data on (single) neurons/astrocytic populations39–42 as well as from data on glioblastoma stem-like cells/
human OB cells43,44.
Proteomic analysis on cultured NSCs derived at different ages revealed that the main five canonical pathways 
highly altered by ageing are related to glycolysis, fatty acid metabolism, propanoate metabolism, protein ubiq-
uitination pathway, and valine, leucine, and isoleucine degradation25. Concordantly, around 75% of the nine 
measured metabolites in our cell populations are related to these biological networks.
The main representative metabolite for both E12 and P1 NSCs is Glc which is related to glycolysis and is essen-
tial for modulation of (cell) development, proliferation and differentiation45. Concordantly, the Glc content was 
also consistent in AD NSCs and almost negligible in OECs whose glial fate has been already established.
Additionally, substantial intracellular Tau amounts specifically characterized NSCs, irrespectively of devel-
opmental age, but not OECs. The higher levels of Tau retrieved in all NSCs may be related to the key role of this 
metabolite in antioxidant response, regulation of SC fate/calcium exchange well as neurotransmission/neuro-
modulation along neural development and neuralization jointed to a neuroprotective and regulative action on 
apoptotic response45,46. The pivotal protective role of Tau in brain physiology is also demonstrated by its altered 
function in several neurodegenerative diseases wherein contributes to neuronal dysfunction and death47.
Essential for the physiological function of NSCs are Tau import48 and the ATP-binding cassette (ABC) trans-
porters pathway which is physiologically involved in the membrane trafficking of several substrates (such as 
ions, sugars, lipids, proteins and drugs49) as well as in the regulation of SC biology50. Adult NSCs are quiescent 
cells able to react and proliferate in response to the environmental clues deriving from the surrounding com-
plex network of neurons, microglia, astrocytes and blood vessels24,45. Interestingly, Tau levels were comparable 
between E12 and P1 NSCs, sharing a common embryonic origin37,48, whereas the highest content in AD NSCs 
may be related to a tighter activation/regulation of ABC transporters able to contrast ageing dysfunctions as well 
as neurodegeneration51.
Physiological brain function depends on a constant neuron-glia crosstalk wherein energy reserves and metab-
olites are actively stored and exchanged between neurons and astrocytes characterized by different, but comple-
mentary metabolic specialization52,53. In particular, recent literature has focused on the key role of astrocytes both 
in brain energy metabolism as well as in regulating synaptic neurotransmission52–54. Astrocytes are also capable to 
connect neurons to the surroundings and influence energy supplementation from circulation (neuro-metabolic/
vascular coupling)52,53. Our data suggest that the metabolic compartmentalization necessary for neuron-astrocyte 
cooperation52,53 may be, at least partially, present early along differentiation starting from stem/progenitor cells.
Figure 6. 2D loading plot of PLS-DA analysis: PC1 vs PC2. In this representation, each point corresponds to a 
bin of the NMR spectrum in a given chemical shift interval. The ellipse is a guide for eyes to separate clustered 
and scattered points. The points scattered outside the ellipse are associated to those parts (bins) of the NMR 
spectrum mostly responsible for the discrimination of SC types observed in the score plot and previously 
discussed (see Fig. 3 and text). The numbers aside the points correspond to the chemical shift of the bin.
www.nature.com/scientificreports/
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Although considerable storage of Ace and Lac is classically linked to metabolic pathways inside astrocytes52,53, 
our data suggest that they are also fundamental for both NSC and OEC maintenance, probably in relation to their 
key role in preserving SC state and homeostasis14.
The shuttle of branched amino acids/ketoacids between astrocytes and neurons appears fundamental for 
replenishing brain Glu reserves55 in conjunction with Ace astroglial trafficking56. As detected by both 13C-NMR41 
and in vivo 1H-[13C] magnetic resonance spectroscopy (MRS)57, the cell specific Ace uptake activates a glial meta-
bolic pathway ending with the production of glutamine which can be transported to glutamatergic and GABAergic 
neurons for replenishing the neurotransmitter Glu (Glu-glutamine cycle) after synaptic transmission58,59. 
Glutamate is the major excitatory neurotransmitter of the brain which connects carbohydrate and amino acid 
metabolism via the tricarboxylic acid (TCA) cycle52,53 and it may act as a regulator of adult neurogenesis/dif-
ferentiation60,61. Interestingly, we retrieved that Glu content is significantly increased in AD NSCs probably in 
relation to the crosstalk between neurogenesis and neurotransmitter signaling62,63 required for their “on demand” 
activation. In the adult niche NSCs are quiescent, but require rapid proliferation followed by differentiation to 
guarantee tissue homeostasis and renewal, especially in the presence of brain injury/damage24. Therefore, it is not 
surprising that AD NSCs possess peculiar hallmarks different from both OECs and their embryonic/postnatal 
counterparts, such as the highest Glu content. Moreover, we retrieved relevant and comparable levels of Glu and 
Suc in OECs and in the younger NSC types (E12, P1) whereas AD NSCs contained the highest (statistically sig-
nificant) metabolite amounts. Concordantly, the key role of Suc and other molecules related to Krebs cycle (such 
as Glu) on stemness has been demonstrated in the physiological proliferation of AD NSCs64 coupled to their 
decrease in a human immortalized striatal neural SC line along differentiation65.
The retrieved comparable intracellular Lac content between AD and OEC samples is supported by literature 
data on the limited in vivo assignation of a specific glycolytic flux to any brain cell types by NMR spectros-
copy59. Our data suggest that relevant Lac content is equally fundamental for the preservation of both NSCs 
and glial committed OECs, probably in relation to its involvement in antioxidant defense and SC homeostasis. 
Concordantly, metabolism of pluripotent and multipotent stem cells depends on glycolysis with hyperlactate 
production45. As matter of fact, all NSCs showed lower, but comparable content for Lac, indicative of a highly 
glycolytic metabolism, as already demonstrated in human NSCs66, whereas a decrease in Lac content has been 
already linked to the process of NSC differentiation45. Concordantly, astrocytes store higher Lac amounts as 
energy supply to the high energy demanding neurons of surrounding areas via a specialized shuttle transport67, 
as our OECs statistically did in comparison to E12/P1 NSCs.
Alanine is a highly gluconeogenic amino acid and was retrieved among more representative metabolites only in 
P1 OECs encompassing almost 40% of their main analyzed metabolites along with some aromatic amino acids, which 
specifically characterize OECs. Alanine appears involved in a variety of brain biological pathways including glyco-
lysis, fatty acid and amino acid metabolism, citrate and urea cycle as well as Tau and hypotaurine metabolism41,68. 
This latter metabolic pathway is linked to the astrocyte specific antioxidant and neuroprotective capability to con-
trast endogenous ROS52,53. Moreover, similarly to astrocytes, the metabolic content in OECs suggests a possible 
active role of these cells also in neuromodulation as well as neurotransmitter synthesis and function. Altogether 
our data indicated that OECs and astrocytes appeared to share several metabolic hallmarks and may be equally 
able to support neuronal activity, but in different localization of the nervous system27,38. Concordantly to our 
observations, a developmental differences in Glu metabolism and neurotransmitter synthesis between postnatal 
and adult brain has been reported69.
Interestingly our analysis on brain SC/progenitor cells also enlightened an overlapping metabolic pathway 
redundancy able to guarantee a fine tuning of proliferation combined to the highest antioxidant defense.
Contrary to the literature, we did not observed NMR-detectable mobile lipids17 nor apoptotic peaks70, but 
these discrepancies may be related to the procedures for sample preparation. Additionally, NSCs are characterized 
by very low intensity or absent lipid signals that are instead more frequently observed in cancer SCs43.
Altogether, the retrieved data suggest that several aspects of metabolism may distinguish NSCs from their 
differentiated counterparts (OECs). All the metabolites contained in OECs are functionalized to their supportive 
role to the surrounding neurons whereas the NSC differential activities, at least between fetal/postnatal and adult 
life, are mirrored by their metabolomes. Apparently, OECs and NSCs present a univocal characteristic metabolic 
signature, able to determinate their fate and properties, as already demonstrated for adult NSCs71. This tight 
regulation appears preserved even when cells are induced to proliferate and maintained under artificial culture 
conditions. Our findings also suggest that multivariate analyses of NMR spectra may be exploited as an effective 
tool for the selective (SC) identification in addition to the standard immuno-biochemical investigations.
Mapping the physiological or pathological neurochemical profile of SCs by NMR may represent an invaluable 
tool readily transferable from research to therapeutic clinical interventions. Interestingly, as recently highlighted 
by Gebregiworgis and Powers18, in a decade of failures of proteomics72, NMR metabolomics might turn out to also 
become an efficient, alternative tool in the search of human (disease) specific biomarkers.
Overall our data provide a detailed description of the metabolic fingerprinting of cultured brain cell subtypes 
which deserves to be further validated and deepened. The observed metabolome appears to be unaffected by 
extensive cell culturing and correlates to the specific tissue derivation, (stem) characteristics and properties. Our 
study also shows that NMR analysis may efficiently characterize AD NSCs, otherwise indistinguishable from 
embryonic/postnatal NSCs. Here we also provide a detailed metabolic characterization of cultured OECs which, 
at the best of our knowledge, has never been previously described. Therefore, the unambiguous clustering of 
NMR data either by quantitative or multivariate analysis could define the physiologic homeostasis and properties 
of the SC pool in different environments or describe their alterations in pathological conditions (such as ageing 
and neurodegeneration). Importantly, such strategy requires cooperation and integration among several method-
ologies and fields of expertise in order to provide a better description of biological features translatable into novel 
methodological or therapeutic approaches.
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Materials and Methods
Availability of materials and data. All data generated or analyzed during this study are included in this 
published article (and into the related Supplementary Information files).
Animals. Experiments were performed on CD1 mice obtained by Charles River Laboratories Italy). Animals 
were kept in a controlled environment (23 ± 1 °C, 50 ± 5% humidity) with a 12 h light/dark cycle with food and 
water available ad libitum. Experiments were performed in compliance with the Italian law and in accordance 
with the European Community Council Directive (86/609/EEC). All the experimental procedures were carried 
out and authorized in accordance with Italian Law 26/2014. The research protocol was approved by the ethics 
committee of IRCCS Istituto Auxologico Italiano. Animals were kept at the dedicated Animal Facility afferent to 
our Institute wherein we performed animal sacrifices at the specified time points. All possible efforts were made 
to reduce both the number of animals as well as their suffering.
NSC derivation from SVZ. Cortexes of E12.5 embryos (8–10 littermates for each experiment) and SVZs 
from postnatal P1 (8–10 littermates for each experiment) as well as adult (AD) (1 animal for each experiment) 
were dissociated to obtain single NSCs, as schematized in Supplementary Fig. S1. They could be indefinitely 
grown in suspension as neurospheres in proliferative medium (DMEM/Ham’s F12 medium, Invitrogen-Thermo 
Fisher Scientific, Waltham, MA, USA) supplemented with B27 (Invitrogen-Thermo Fisher Scientific), 5 mg/ml 
heparin (Sigma-Aldrich, St. Louis, MO, USA), plus mitogens: 20 ng/ml basic Fibroblast Growth Factor and 50 
ng/ml Epidermal Growth Factor (both from Peprotech, Rocky Hill, NJ, USA)73. All cultures were analyzed in 
triplicate and 5 different cultures for each SC type were performed.
Primary OB-derived OEC cultures. Primary OEC cultures were obtained from the olfactory bulbs of 
postnatal mice (P1, 8–10 littermates for each experiment), which were dissociated, as previously described74. 
OECs were cultured in DMEM (high glucose) (Invitrogen-Thermo Fisher Scientific) +10% Fetal Bovine 
Serum (FBS, Sigma-Aldrich), 2 mM L-glutamine, penicillin (50 U/ml) and streptomycin (50 µg/ml), all from 
Invitrogen-Thermo Fisher Scientific. All cultures were analyzed in triplicate and 3 different cultures for each SC 
type were performed.
Stemness potential and differentiative capability of our cells were previously tested according to published 
literature24,26,73.
Preparation of SC lysates for NMR analyses. The same amount of cells was analyzed (3 × 106 cells/SC 
type). Adherent OECs (3 × 106 cells/SC type) were then harvested by trypsin digestion (as previously detailed74) 
while free-floating NSCs were collected by simple centrifugation, 200 relative centrifugal force (rcf), and rinsed 
with 5 ml of Phosphate-Buffered Saline buffer (PBS, Sigma-Aldrich). Upon centrifugation at 4,000 rcf for 1 min, 
cell pellets were kept on ice for 5 min before being resuspended in 1 ml of ice-cold 50% acetonitrile (VWR, 
Radnor, PA, USA) in PBS. Cell suspensions were kept on ice for 10 min before centrifugation at 16,000 rcf for 
10 min at 4 °C. The aqueous acetonitrile extract method was chosen in accord with previous literature28. A total 
number of 51 samples (12 samples for each NSC type and 15 samples for OECs) were analyzed.
NMR Spectroscopy. General. The aqueous acetonitrile extract solutions were dried down by a suit-
able concentrator (Savant SpeedVac®Concentrator, Thermo Fisher Scientific) and the resulting white resi-
due was dissolved in 60 µl of PBS-Deuterium Oxide (PBS-D2O, as detailed below) stock solution buffered at 
pH = 7.0. The solution is further diluted in 540 µl of D2O containing trimethylsilyl-3-propionic acid (TSP, 
Sigma Aldrich) 1 mM as internal standard and then transferred in a 5 mm NMR tube. The PBS-D2O stock 
solution was obtained by dissolving a PBS tablet (Sigma-Aldrich) in D2O (Sigma-Aldrich) at a concentrations 
of 9.8 mg/ml.
All the NMR spectra were recorded on a Bruker Avance 500 spectrometer, Bremen Germany, operating at 
500.13 MHz proton frequency and equipped with a QNP four-nuclei switchable probe. Standard 1H-NMR spectra 
acquisition were performed using residual water presaturation pulse sequence, spectral window SW = 5400 Hz, 
relaxation delay D1 = 4 s, 32 K points for acquisition, 512 scans. The two-dimensional TOtal Correlation 
SpectroscopY experiments (2D-TOCSY) were acquired with mixing time of 200 ms, SW = 5400 Hz, D1 = 4 s, 
2k data points in F2 dimension and 512 FIDs in the F1 dimension. For all the experiments, the temperature was 
kept constant at 305 K.
All the one-dimensional NMR spectra were phase-corrected manually, while the baseline correction was per-
formed automatically with a fifth order polynomial fitting routine. TSP was used as internal reference standard 
(0 ppm) for spectra calibration. The peak area was determined manually for each resolved peak representative 
of a single metabolite and then normalized respect to the TSP signal area. The final metabolite concentration is 
expressed as mM and reported in Fig. 2 for each cell line.
The assignment of the metabolite signals for each cell line was supported by the use of two-dimensional cor-
relation NMR methods. In particular, 2D total correlation spectroscopy (TOCSY) experiments were extensively 
used.
Multivariate analyses: PCA and PLS-DA. The first step in order to carry out PCA and PLS-DA is the so 
called “spectral binning”. After the NMR data processing described in the NMR section, spectral binning was per-
formed on the 1D spectra by reducing the spectrum data points (32 k points) into a smaller number of segments 
(bins) of a defined width (0.04 ppm). The spectral area within each bin is then integrated to yield a vector that 
contains intensity based descriptors of the original spectrum. Binning was performed using MNova 6.0 software 
package (Mestrelab Research, Santiago de Compostela – Spain).
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The data were then imported into Metaboanalyst 3.0, an online tool freely available at www.metaboanalyst.ca75. 
PCA and PLS-DA were performed on a wide spectral region, 0.5–9.5 ppm (the region from 4.5 to 5 ppm was 
blocked out due to water suppression artifact). Normalization for all of the spectral binning data is performed on 
the total area of the NMR spectrum. This is achieved by calculating the sum of all the variables within a spectrum 
and by normalizing each spectrum on such value. In this way, every single variable is converted to a fraction of the 
total spectral area or intensity. Pareto scaling is then applied. Accordingly, the variable mean was subtracted from 
each variable (column of the data) and then each variable was divided through the square root of its standard 
deviation. The raw data were then exported into Origin 9.0 in order to create three-dimensional graphs.
PLS-DA is a supervised mathematical method able to enhance the cluster separation already obtained with 
the PCA method. For PLS-DA, the best linear combination of the original PCs are used as new variables. The 
results are shown in Fig. 4. Cross-validation was achieved by the leave-one-out validation protocol followed by 
the permutation test (n = 100).
Quantification of extracellular Lac levels. Analysis was conducted by a kit (Glycolysis Cell Based Assay 
Kit Cayman Chemical Company, Ann Arbor, MI, USA) for the quantification of extracellular L-Lac levels (the 
end product of glycolysis) which are proportionally correlated with intra-cellular glycolytic activity. Briefly, cells 
deriving from 2 different cultures for each NSC type (15.000 cells/well) were plated in duplicate in 96 wells and 
cultured for 60 hours. Afterwards, standards and samples (10 µl of cell conditioned media as well as an equal 
amount of cell-free media, NSC and OEC medium) were processed and analyzed following the manufacturer’s 
instructions. L-Lac levels were calculated subtracting the absorbance levels of the corresponding cell-free media 
and corrected for the total cell number in each well.
Determination of Glc content and uptake from media. Quantitative analysis of Glucose (Glc) content 
in media was performed on 0.5 ml of NSC/OEC medium. Cells (25.000 cells/ml) were grown for the indicated 
times (5 or 7 Days In Vitro, DIV) and thereafter their media were collected and analyzed by NMR. Concentrations 
of Glc were calculated as difference between their value in naïve medium and the retrieved amount after cell 
growth. Each sample was prepared in triplicate and all data were normalized for the total cell number.
Statistics. Each experiment was run in triplicate and representative values were expressed as mean ± SD. 
Data were analyzed using One way ANOVA analysis followed by uncorrected Fisher’s LSD (the corresponding p 
is specified in the respective figure or table), using a dedicated statistical software (GraphPad Prism, Inc., La Jolla, 
CA, USA). Metabolic pathways were investigated by the KEGG PATHWAY Database – GenomeNet, free available 
online at: www.genome.jp/kegg/pathway.html.
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